Low-affinity anti-HER2-CAR T cells efficiently eradicate HER2(+) and HER2(low) cancer cells with reduced toxicity on healthy tissue.
Knoedler L, Herfeld K, Scherer JN, Fan K, Shah D, Goettert S, Becker L, Lloshi I, Li S, Harrer DC, Fante MA, Wertheimer T, Schelker R, Guetter S, Tariq M, Khalid O, Scheiter A, Herr W, Schmidl C, Jesinghaus M, Tschurtschenthaler M, Poeck H, Perl M
The online reader was unable to display this document directly. This may occur if the repository host is temporarily unreachable, or if security restrictions (CORS) prevent embedded viewing.